London, United Kingdom

Bart Vanhaesebroeck

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 117(Granted Patents)


Location History:

  • London, GB (2002 - 2015)
  • Charterhouse Square, GB (2017)

Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Bart Vanhaesebroeck: Innovator in Vascular Health

Introduction

Bart Vanhaesebroeck is a notable inventor based in London, GB, recognized for his contributions to the field of vascular health. He holds a total of four patents, showcasing his innovative approach to addressing critical health issues.

Latest Patents

One of his latest patents focuses on the use of PI3KC2B inhibitors for the preservation of vascular endothelial cell barrier integrity. Ischemic conditions are a leading cause of death for both men and women. Ischemia is characterized by reduced blood flow and oxygen to an organ. The re-establishment of blood flow, or reperfusion, and re-oxygenation of the affected area following an ischemic episode is critical to limit irreversible damage. However, reperfusion can also lead to potentially damaging consequences. Increased vascular permeability is an important contributor to edema and tissue damage following ischemic events. In this patent, the inventor demonstrates that genetic inhibition of PI3K-C2β reduces cerebral infarction in two ischemia/reperfusion (I/R) models and improves neurological outcomes. The genetic inhibition stabilizes the blood-brain barrier (BBB) after ischemic stroke and reduces inflammation. Accordingly, the present invention relates to a method for preserving vascular endothelial cell barrier integrity in a patient in need thereof, comprising administering a therapeutically effective amount of a PI3KC2β inhibitor. Another significant patent involves a method for identifying the activation of transferases, providing a means to identify differential activation of a bisubstrate protein modifying enzyme between samples.

Career Highlights

Throughout his career, Bart has worked with several prominent organizations, including Hvivo Services Limited and the Ludwig Institute for Cancer Research Limited. His work in these companies has contributed to advancements in medical research and innovation.

Collaborations

Bart has collaborated with notable colleagues such as Pedro Rodriguez Cutillas and Michael Derek Waterfield, further enhancing his research and development efforts.

Conclusion

Bart Vanhaesebroeck's innovative work in vascular health and his significant patents highlight his commitment to improving medical outcomes for patients. His contributions are vital in the ongoing fight against ischemic conditions and their associated complications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…